Disclosures: Ai-Thien Do: Nothing to Disclose, Ming-Lung Yu: Abbvie, Gilead and Roche diagnostics.: Grant/Research Support, Abbott, Abbvie, Gilead, Roche and Roche diagnostics: Consultant, Abbvie, BMS, Gilead, Roche and Roche diagnostics: Speaking and Teaching, Hidenori Toyoda: Nothing to Disclose, Seng Gee Lim: Nothing to Disclose, Ramsey Cheung: Nothing to Disclose, Man-Fung Yuen: Nothing to Disclose, Yasuhito Tanaka: Nothing to Disclose, Wan Long Chuang: Gilead: Speaking and Teaching, AbbVie: Speaking and Teaching, BMS: Speaking and Teaching, Vaccitech: Consultant, PharmaEssentia: Consultant, Chao Wu: Nothing to Disclose, Maria Buti: Nothing to Disclose, Nothing to Disclose, Adrian Gadano: Nothing to Disclose, Ming-Lun Yeh: Nothing to Disclose, Chung-Feng Huang: Nothing to Disclose, Rui Huang: Nothing to Disclose, Jee-Fu Huang: Nothing to Disclose, Chia-Yen Dai: Nothing to Disclose, Mayumi Maeda: Nothing to Disclose, Kaori Inoue: Nothing to Disclose, Chul-Jin Lee: Nothing to Disclose, Cheng-Hao Tseng: Nothing to Disclose, Ana Barreira: Nothing to Disclose, Rex Wan-Hin Hui: Nothing to Disclose, Kwan-Lung Ko: Nothing to Disclose, Yoko Yoshimaru: Nothing to Disclose, Takanori Suzuki: Nothing to Disclose, Irina Sandra: Nothing to Disclose, Raluca Marin: Nothing to Disclose, Vy Nguyen: Nothing to Disclose, Yao-Chun Hsu: Gilead Sciences: Grant/Research Support, Gilead Sciences: Advisor, Sysmex: Advisor, Abbvie: Speaking and Teaching, Bristol Myers Squibb: Speaking and Teaching, Gilead Sciences: Speaking and Teaching, Roch: Speaking and Teaching, Huy Trinh: Nothing to Disclose, Jiayi Li: Nothing to Disclose, jianqing zhang: Nothing to Disclose, Eiichi Ogawa: Gilead Sciences: Grant/Research Support, Dong Hyun Lee: Nothing to Disclose, Takanori Ito: Chugai Pharmaceutical Co., Ltd.: Grant/Research Support, Chugai Pharmaceutical Co., Ltd
It may be of potential value in the treatment of Parkinsons disease (Gal et al., 2005)
10.5851/kosfa.2015.35.2.164 [DOI] [PMC free article] [PubMed] [Google Scholar] Parker A., Romano S., Ansorge R., Aboelnour A., Le Gall G., Savva G
Sirtuins are known to influence the body's response to oxidative stress and inflammation, and their dysregulation could lead to increased oxidative damage and reduced ATP production (Sara et al., 2021), further exacerbating symptoms of fatigue and metabolic dysfunction
